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Summary.-Pulse doses of N-dibutylnitrosamine(DBN), N-butyl-N-(4-hydroxy-
butyl)nitrosamine(BBN) and N-butyl-N-(3-carboxypropyl)nitrosamine(BCPN) sus-
pended in 10% gelatin, were administered s.c. to infant CDF1 mice, and the experiment
terminated at one year of age. Tumours were induced in lungs and liver. The
incidences of lung adenomas were 73-95%O in all treated mice, with no sex differ-
ences. Hepatocellular adenomas and a carcinoma were found with an incidence
of 81% (21/26) in DBN, 59%o (13/22) in BBN, and 32% (9/28) in BCPN-treatedmales
and the incidence was 23% (5/22) in DBN-treated females. Only one papilloma
of the fore-stomach was induced in mice treated with DBN. These results indicated
that the s.c. administration of DBN, BBN, and BCPN induced tumours of the lung
and liver, but no tumours of the urinary bladder, under these experimental condi-
tions. The carcinogenic effect on mice at the treated dose level was DBN > BBN >
BCPN.
N-DIBUTYLNITROSAMINE(DBN), N-bu-
tyl - (4 - hydroxybutyl)nitrosamine(BBN),
and N-butyl-N-(3-carboxypropyl)nitros-
amine(BCPN) are potent carcinogens
among the dialkylnitrosamines, in their
ability to induce tumour of urinary blad-
der in rodents, when the administration
is started in young animals (Druckrey et
al., 1964; Ivankovic and Bucheler, 1968;
Ito et al., 1969; Bertram and Craig,
1970, 1972; Wood, Flaks and Clayson,
1970; Hashimoto, Suzuki and Okada,
1972, 1974; Okada and Hashimoto, 1974).
Druckrey et al. (1964) have reported
a selective incidence of urinary bladder
tumours in BD rats administered with
DBN and its hydroxylated derivative,
BBN. In mice, Wood et al. (1970)
have reported that 3 injections of 1,al
DBN to infant animals induced tumours
of liver and lung rather than of urinary
bladder. Okada and Suzuki (1972) have
studied the metabolism of BBN in rats,
and found that a majority of BBN
administered orally to rats was excreted
in the urine as BCPN, which selectively
induced urinary bladder tumour in rats
(Hashimoto et al., 1972). Recently, the
interesting finding was reported by Hashi-
moto and Kitagawa (1974) that rat
epithelial cells of urinary bladder were
transformed by BCPN or BBN with
urea in tissue culture.
In this paper, the carcinogenic activity
of DBN and two of its derivatives, BBN
and BCPN, have been studied in newborn
mice, and comparison was based on the
affected tissues. To date, no comparable
report on incidences of tumours in DBN-,
BBN-, and BCPN-treated mice, when
carcinogen was administered at birth, is
available.
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MATERIALS AND METHODS
Animals. Pregnant female BALB/c mice
mated with DBA/2 males were supplied by
Dr K. Suzuki, Institute of Medical Science,
University of Tokyo, Japan. After birth,
(BALB/c x DBA/2) F1 mice (CDF1) were
nursed by their mother, and after weaning
they were maintained on CE-2 pellet diet
(CLEA Japan Inc., Tokyo) and water ad
libitum.
Chemicals.-N-Dibutylnitrosamine(DBN),
N - butyl - N - (4 - hydroxybutyl) - nitrosam -
ine(BBN), and N-butyl-N-(3-carboxypropyl)-
nitrosamine(BCPN) were synthesized by Dr
M. Okada, Tokyo Biochemical Research
Institute, and the purity of these chemicals
was analysed using thin-layer chromato-
graphy, infra-red nuclear magnetic resonance
and mass spectra. Gelatin was purchased
from Difco Laboratories, Detroit, Mich.
Each test chemical was prepared freshly
in 10% gelatin solution by using a magnetic
stirrer at room temperature.
Ani,mlal treatment.-Newborn CDF1 mice
within 24 h after birth were injected s.c.
on the back with 0 03 ml of 1% gelatin
solution containing 158 [kg DBN (105 pug/g
body wrt), 87 Htg BBN (58 ,tg/g body wt),
or 188 jug BCPN (125 Htg/g body wt), respec-
tively, and thereafter once a week for 3
weeks (a total of 4 injections). The doses
used were the maximum tolerated dose
(MTD) of each chemical in newborn CDF1
mice, and the MTD was determined by the
method described elsewhere (Fujii et al.,
1976).
Animals were weaned at one month of
age and separated by sex. Five or fewer
animals were housed in each plastic box
with sawdust bedding in an environmentally
controlled room. They were observed daily
for mortality and sickness, and all animals
were weighed monthly. The study was
terminated at one year in all groups, and
surviving animals necropsied. Complete ne-
cropsies were performed on moribund and
dead mice, or on those killed at the termina-
tion of the experiment. Tissues were fixed
in 10% neutralized formalin solution, sec-
tioned at 3 ,tm, and stained routinely with
haematoxylin and eosin. Special stains were
used on restricted occasions.
Statistical analysis.-Statistical analysis
of tumour incidence was made with the
Chi-square test.
RESULTS
Weaning rates and survival rates
Experimental groups, number of sur-
viving animals and total tumour incidence
are listed in Table I.
A total of 200 newborn mice from
29 dams were separated randomly into
4 groups, including a vehicle control.
Of these, 930o (142/153) of the animals
in the Groups 1-3 were weaned at one
month of age, compared with 77% (36/47)
in the control. Eighty-seven per cent
(126/142) of animals survived at the
termination of the study at one year,
and 970 (35/36) in the control.
Incidence of tumours
Before termination of the experiment,
17 animals died or were killed when
moribund. Most ofthem died ofbroncho-
pneumonia, or urinary tract inflammation.
Of these, 4 animals bore lung adenomas
and/or hepatocellular adenomas. The first
appearance of a tumour was at 39 weeks.
The overall incidences of tumours
in Groups 1-3 were statistically significant
(77-95oo; X2 19-43-40-30, P < 0.005)
compared with the control (0 Y and 170%
S, respectively). Though the overall inci-
dences in each group were similar, the
effect on Group 3 (BCPN) appeared less,
and the difference in incidence between
the groups was not statistically significant
(X2
= 3.08, P > 0.05). The overall inci-
dences were confined to the lung and
liver.
Lung tumour
Incidences of lung tumour in Groups
1-3 were 73 to 950o as shown in Table II.
They were not linked to sex, although
the incidences in the females were slightly
greater than in the males.
Most of the tumour nodules in Groups
1-3 were multiple, and the average
number of tumours per animal was
higher in Group 2 (BBN). All lesions
were diagnosed as lung adenomas. The
multiplicity of tumours was higher in
Groups 2 and 3 than in Group 1, as
shown in Table II.
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TABLE I.-Survival and Tumour Incidence in CDF1 Mice Given N-Dibutylnitrosamine,
N-Butyl-(4-hydroxybutyl)nitrosamine, or N-Butyl-(3-carboxypropyl)nitrosamine by s.c.
Injections to Newborn
Dose
No. of
animals
No.
of
No. of
animals
roup Chemical injected injected litters weaned Sex
1 DBN 158 ug x 4 52 7 48 M
F
2 BBN 87 ,ug x 4 46 7 44 M
F
3 BCPN 188 lug x 4 55 8 50 M
F
4 Vehicle 0-03 ml 47 7 36 M
control F
No. of survivors at risk
(wks)
4 10 20 30 40 50
26 23 23 22 22 22
22 22 22 22 22 22
22 22 22 21 20 19
22 22 22 22 21 20
28 23 23 23 22 22
22 21 21 21 21 21
18 18 18 18 17 17
18 18 18 18 18 18
Animals were killed 52 weeks after the start of the experiment.
* Percentages based on the number of animals weaned at 4 weeks.
TABLE II.-Organ Distribution ofTumours
Group Chemical
1 DBN
2 BBN
3 BCPN
4 Vehicle control
Sex
M
F
M
F
M
F
M
F
Lung tumours
No. % No./animal
19 73 1-6
19 86 2-5
19 86 3-1
21 95 3-3
22 79 2-5
17 77 2-5
2 11 0-1
0 -
Liver tumours
No. % No./animal
21 81 10-2
5 23 2-5
13 59 2-8
0 -
9 32 0 4
0 -
1 6 0.1
0 -
Percentages based on number of animals at weaning.
* Papilloma of the fore-stomach.
Liver tumour
Liver tumours were predominantly
in the males (32-81%), but there were
a few tumours in the females (23%)
ofGroup 1. The incidences were statistic-
ally significant (X2 4-55-24*09, P <
0.05). Vehicle control showed 6% (1/18)
liver tumours in males and none infemales.
The incidence and average number of
liver tumours per animal were higher
in Group 1 (DBN) males than in Groups
2 and 3 males (BBN, BCPN) as shown
in Table II. The incidences and the
average number of tumour nodules per
animal were in the order of DBN >
BBN > BCPN, regardless of the molar
dose of chemical and the solubility of
chemical in animal tissues.
All except one tumour were classified
as hepatocellular adenomas. The excep-
tion, in the males of Group 1 (DBN),
was a hepatocellular carcinoma occupying
the entire left lateral lobe, and the
lesion measured 18 mm by 13 mm. Micro-
scopically, the tumour cells were arranged
in a trabecular pattern and the cell
arrangements were irregular, with no
metastatic foci in any remote organs.
Other tumours
There was only one papilloma of the
fore-stomach, in a male of Group 1
(DBN).
Other lesions than tumours
A few pathological lesions found in
mice in this experiment were broncho-
pneumonia, hepatitis, urinary tract in-
flammation and otitis media.
The urinary tracts were carefully
examined and, in a few cases, thickened
mucosa of the urinary bladder without
Tumour-
bearing
animals
No. (%)*
22 (85)
20 (91)
19 (86)
21 (95)
24 (86)
17 (77)
3 (17)
0
Other tumours
No. %
0 -
1* 5
0
0
0
0
0
0
Animals with
lung and liver
tumours
18
5
13
0
9
0
0
0
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round-cell infiltration was found, but
there was no other specific finding for
either carcinogen-treated or control
groups.
DISCUSSION
Our results indicate that s.c. injection
of DBN, and its two derivatives BBN
and BCPN, induced tumours of the lung
and liver ofmice, but not urinary bladder,
when the injection was given on Day 1
oflife and followed by 3 weekly injections.
In one study, newborn mice treated with
DBN developed tumours of the liver
and lung (Wood et al., 1970), but in this
study DBN, BBN and BCPN also in-
duced such tumours. There was no sex
difference in the incidence oflung tumour,
but liver tumours were mainly in male
mice.
In the report by Wood et al. (1970),
1,l of DBN in newborn (IF x C57)F1
mice was 900 ,ug (if the sp. grav. of
DBN was 0 9). However, a total dose
632 ,ug of DBN (158 ,ug x 4) in our
experiment was 4-27 times lower than
that (900,ug x 3) by Wood et al., regard-
less of the strain differences.
One aim of this experiment was
to develop an appreciable yield of urinary
bladder carcinomas. However, in the
present effort, we failed to induce urinary
bladder tumour in mice. Available re-
ports deal with a high and selective
incidence of urinary bladder tumour
when the administration of DBN and
its metabolites was given s.c. or orally
to adult rats and mice (Druckrey et
al., 1964; Ivankovic and Bucheler, 1968;
Ito et al., 1969; Bertram and Craig,
1970, 1972; Wood et al., 1970; Hashimoto
et al., 1972, 1974). However, no bladder
tumours have yet been reported to be
induced in newborn mice with a limited
amount ofchemical carcinogen. We have
confirmed this with DBN and its deriva-
tives BBN and BCPN.
Recently, one study showed that
mucosal cells of the urinary bladder in
rat were made neoplastic with the com-
bination of urea and either BCPN or
42
BBN in vitro (Hashimoto and Kitagawa,
1974). This result suggests that urea
in the bladder may also play an important
role in transforming mucosal cells of
urinary bladder into neoplastic cells in
vivo. The relative concentrations of urea
and carcinogen may be a factor in
affecting mucosal cells.
The target tissues in newborn mice
differ from those in adults (Takayama
and Imaizumi, 1969). It may be reason-
able to presume that the differences in
target tissues of adult and infant mice
can be due to strain, age, variety of
chemical susceptibility in cells, duration
of chemical exposure, absence or by-
passing of the activation steps of chemi-
cals in newborn, slow excretion of the
chemical, and ineffective amounts of
carcinogen in urinary bladder due to
longer retention of chemical in the body.
This study emphasizes that age dif-
ference at administration of carcinogen
to mice, especially newborn, can vary
their responses to carcinogenic chemicals.
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